Global Cell-based Assays Market Overview:
Cell-based assays take place within a living cell. It is grouped into cell signaling assays, reporter gene assays, cell death assays, and cell proliferation assays. It is a preclinical development tool used in the pharmaceutical industry and research laboratories to reverse the increasing trend of costly late-stage drug failures and save investments. Cell-based assays lower the downstream cost and reduce animal models, which are used for toxicity and metabolism study and can be expensive and reason to drug failures at the late stage of preclinical testing. Also, animal models may not always replicate human metabolism, which can result in late-stage failure.
Global Cell-based Assays Market Insights
The global cell-based assays market size is growing at a significant CAGR during the forecast period, 2020-2027. The growing demand for cell-based assays is rising drug discovery activities and increasing R&D investments. Additionally, the increasing utilization of cell-based assays in the pharmaceutical& biotechnology industry and CROs will spur the global cell-based assays industry in the future periods. Furthermore, the growing public-private funding for cell-based assays and the easy research in the area of stem cell, cancer immunology, and immunogenicity is expected to witness remarkable growth of cell-based assays. The increasing clinical usage of cell-based assays in pharmacology, including cytotoxicity testing, development of novel small molecules, bio-therapeutic and cell-based therapies, are expected to propel the demand for cell-based assays over the coming years.
Moreover, the upsurge in demand for cell-based assays in pharmaceutical industries to overcome the expensive failure of last-stage drugs and failure of investigation of new drugs is positively impacting the market for cell-based assays in the healthcare industry. Furthermore, the rapidly enlarge customer base, rise in the extensive R&D activities at the academic and industrial level, and increasing scope of high-throughput screening formats are fueling the demand for cell-based assays in the healthcare market. The rising adoption of label-free cell-based assays with optical biosensors in drug discovery will bolster the growth of the global cell-based assays market share. The growing geriatric population and increasing healthcare awareness in the developing world propelling the maturation of the cell-based assays market across the globe.
Growth Driver
A cell-based assay is used to manufacture novel drugs, which can effectively reduce the manufacturing cost and investigate basic cell biology and its relation to disease pathology. Due to huge advantages such as the possibility of automation, miniaturization, predictability, and multiplexing seem the most useful tool for the high demands of the early stages of the drug-discovery process. Improvements made in high content systems and technological developments have attracted various enterprises to the layout. However, the high cost of instruments may restrict the growth of the market. Moreover, the increasing adaptation of high throughput technology in life science research, drug discovery & development, environment monitoring, and biopharmaceutical production process.
Product Segmental Analysis
Based on the product, the global cell-based assays market is segregated into consumables, instruments, services, and software. The consumables segment is further classified into reagents, microplates, probes & labels, assay kits, cell lines, etc. The Consumables segment is estimated to the highest growth over the analysis timeframe due to increasing cell-based assays in drug discovery and increasing biomedical research activities.
The instruments will grow significantly due to the rising adoption in the diagnostics field, analyze complex cellular functions, and measure proliferation, cell viability, cytotoxicity, and a reporter gene.
Application Segmental Analysis
Based on the application, the global cell-based assays market is classified into drug discovery, basic research, ADME studies, predictive toxicology, etc. The drug discovery is to be the highest revenue share for cell-based assays during the forecast period. The segment’s growth is generally attributed to the growing use of the cell-based assays technology in the pharmaceutical & biotechnology industry to determine the biological activity (potency) of a drug product and to save the investment of late-stage drug failures.
The ADME studies will witness a lucrative growth rate in the estimated period due to the increasing demand for cytotoxicity testing and rising R&D investment by pharmaceutical companies.
End-User Segmental Analysis
Based on the end-user, the global cell-based assays market is segmented into pharmaceutical & biotechnology companies, academic and government research institutes, contract research organizations (CRO), other end users. The pharmaceuticals & biotechnology segment will dominate the global cell-based assays market by 2027 due to the increasing use of cell-based assays in a clinical trial setting and novel drug development.
The CMOS accounted for the largest share of the cell-based assays market in 2019 on account of providing more early drug development services and increasing the use of cell-based assays for research activities.
Region Segmental Analysis
The global cell-based assays market is segmented into North America, Europe, Asia Pacific, South America, and Middle East & Africa by geography. North America is estimated to project considerable growth over 2020-2026. It is due to leading industry players offering innovative products, Increasing awareness towards cell-based assays for drug discovery, and increasing healthcare expenditure.
The Asia Pacific will produce a prominent share of the cell-based assays market by 2027. Due to the rise in cell-based assays applications, we are continually improving the healthcare framework in the region and mounting health care amenities in emerging countries such as India and China.
Competitor Analysis
Companies such as Envision TEC, Stratasys Inc., Materialise NV, 3D Systems Software, Bio-Rad Laboratories, Organovo, SOLS, Simbionix, Metamason, RegenHU Ltd., Youbionic, Bio3D Technologies Pte Ltd, 3D Matters Pte Ltd., 3D Systems Corporation (3DS), Ekso Bionics, Roche Pharmaceuticals, Renishaw plc., Robohand, Delcam India, Worrell, mobileOCT, Arkham, Rainbow Biosciences, ALD Vacuum Technologies, and 3T RPD Ltd are the key players in the global cell-based assays market.
Key Stakeholders
- Market research and consulting firms
- Industry associations
- Global cell-based assays manufacturing firm
- Research organizations and consulting companies
- Organizations, associations, and alliances related to cell-based assays
- Regulatory bodies
- Suppliers
- Retailers
The objective of the research
- Market modeling starts out with identifying a target market where historical data exists. A Market may include prediction problems, economic factors, analyzing customer behavior, and identifying new patterns from past events, which helps our consumers to have deep dive into the market.
- Product analysis involves examining product features, costs, availability, quality, and other aspects. Product analysis is conducted to understand potential buyers and measure competition in the market.
- Market Trend and Economic Factors Analysis helps assess potential changes to an economy’s inflation rate, taxes, interest rates, exchange rates, trading regulations, and excise duties that can or have a major effect on the target market.
- Market Segmental Analysis defines an in-depth scenario of the target market by grouping consumers into naturally existing created segments of consumers who share similar product preferences or characteristics.
- The geographical mapping approach helps our clients to understand national or international markets because different consumers in different regions have different needs, wants, and cultural characteristics that can specifically target.
Market Modelling
By Product
- Consumables
- Instruments
- Services
- Softwares
By Application
- Drug discovery
- Basic research
- ADME studies
- Predictive toxicology
- Others
By End-User
- Pharmaceutical and biotechnology companies
- Academic and government research institutes
- Contract research organizations (CRO)
- Other end-users
By Region
- North America
- Europe
- Asia Pacific
- South America
- Middle East & Africa
More Related Reports:
Anechoic Chamber Market
Global Risk Analytics Market
Isothermal Nucleic Acid Amplification Technology (INAAT) Market
Tangential Flow Filtration Market
Personalized Learning Market
Bank Kiosk Market
Hardware in the Loop Market
Transfer Membrane Market
Human Machine Interface Market
Transfer Membrane Market